These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6761568)

  • 1. High-dose cytosine arabinoside: clinical response to therapy in acute leukemia.
    Early AP; Preisler HD; Higby DJ; Brecher M; Browman G; McBride JA
    Med Pediatr Oncol; 1982; 10 Suppl 1():239-50. PubMed ID: 6761568
    [No Abstract]   [Full Text] [Related]  

  • 2. High-dose cytosine arabinoside in the initial treatment of acute leukemia.
    Barnett MJ; Waxman JH; Richards MA; Ganesan TS; Bragman KS; Rohatiner AZ; Lister TA
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):133-8. PubMed ID: 3859927
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of refractory acute leukaemia with high dose cytosine arabinoside.
    Willemze R; Zwaan FE; Keuning JJ; Colpin G
    Br J Haematol; 1982 Jul; 51(3):497-8. PubMed ID: 6954973
    [No Abstract]   [Full Text] [Related]  

  • 4. [Attempt at treatment of acute leukemias with cytosine-arabinoside according to Skipper's method].
    Schwarzenberg L; Mathé G; Hayat M; de Vassal F; Amiel JL; Cattan A; Schneider M; Schlumberger JR; Rosenfeld C; Jasmin C
    Nouv Rev Fr Hematol; 1969; 9(2):199-204. PubMed ID: 4239783
    [No Abstract]   [Full Text] [Related]  

  • 5. Phase I-II clinical and pharmacologic studies of high-dose cytosine arabinoside in refractory leukemia.
    Kantarjian HM; Estey EH; Plunkett W; Keating MJ; Walters RS; Iacoboni S; McCredie KB; Freireich EJ
    Am J Med; 1986 Sep; 81(3):387-94. PubMed ID: 3463209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High dose cytosine arabinoside in the management of refractory acute leukaemia.
    Willemze R; Zwaan FE; Colpin G; Keuning JJ
    Scand J Haematol; 1982 Aug; 29(2):141-6. PubMed ID: 6958004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential use of methotrexate, folinic acid, and cytosine arabinoside in the treatment of acute leukemia.
    Greenberg ML; Waxman S
    Eur J Cancer (1965); 1976 Aug; 12(8):617-23. PubMed ID: 1086210
    [No Abstract]   [Full Text] [Related]  

  • 8. Our experience with cytosine arabinoside in the treatment of acute haemoblastoses.
    Janele J; Rosa L
    Neoplasma; 1973; 20(4):403-11. PubMed ID: 4517058
    [No Abstract]   [Full Text] [Related]  

  • 9. Induction of remission with l-Asparaginase, cyclophosphamide, cytosine arabinoside, and prednisolone in adult patients with acute leukemia.
    Gahrton G; Engstedt L; Franzén S; Gullbring B; Holm G; Höglund S; Killander A; Killander D; Lockner D; Mellstedt H; Palmblad J; Reizenstein P; Skarberg KO; Swedberg B; Udén AM
    Cancer; 1974 Aug; 34(2):472-9. PubMed ID: 4527847
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cytosine-arabinoside in the treatment of acute leukemias].
    Böhnel J; Gingold N; Hermansky F; Pawlowski M; Stacher A
    Wien Med Wochenschr; 1972 Apr; 122(15):203-7. PubMed ID: 4527321
    [No Abstract]   [Full Text] [Related]  

  • 11. Experience with intermediate- and high-dose cytosine arabinoside in relapsed and refractory acute leukaemia.
    Willemze R; Fibbe WE; Zwaan FE
    Neth J Med; 1983; 26(8):215-9. PubMed ID: 6580554
    [No Abstract]   [Full Text] [Related]  

  • 12. High-dose cytosine arabinoside in the treatment of childhood malignancies.
    Lie SO; Slørdahl S
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):160-5. PubMed ID: 3859931
    [No Abstract]   [Full Text] [Related]  

  • 13. Central nervous system toxicity of high-dose cytosine arabinoside.
    Barnett MJ; Richards MA; Ganesan TS; Waxman JH; Smith BF; Butler MG; Rohatiner AZ; Slevin ML; Lister TA
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):227-32. PubMed ID: 3925559
    [No Abstract]   [Full Text] [Related]  

  • 14. [Sequential combination of high-dose cytosine arabinoside and L-asparaginase in the treatment of refractory acute leukemia and malignant lymphoma].
    Shimazaki C; Fujita N; Nakanishi S; Nishio A; Haruyama H; Nakagawa M; Ijichi H
    Gan To Kagaku Ryoho; 1985 Nov; 12(11):2202-7. PubMed ID: 3864396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of cytosine arabinoside (ara-C) and high-dose ara-C in acute leukemia.
    Zittoun R; Marie JP; Zittoun J; Marquet J; Haanen C
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):139-43. PubMed ID: 3859928
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cytosine arabinoside in the therapy of acute leukoses].
    Quaglino D; De Pasquale A; Curci G; Montero C; Piccinini L
    Minerva Med; 1971 Jun; 62(45):2271-82. PubMed ID: 5281484
    [No Abstract]   [Full Text] [Related]  

  • 17. High-dose cytosine arabinoside in combination with mitoxantrone for the treatment of refractory acute myeloid and lymphoblastic leukemia.
    Hiddemann W; Kreutzmann H; Straif K; Ludwig WD; Mertelsmann R; Planker M; Donhuijsen-Ant R; Lengfelder E; Arlin Z; Büchner T
    Semin Oncol; 1987 Jun; 14(2 Suppl 1):73-7. PubMed ID: 3473685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experience with the use of cytosine arabinoside in adult acute leukaemia.
    Brodie GN; Penny R
    Med J Aust; 1970 Mar; 1(13):635-7. PubMed ID: 5267173
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical use of cytosine arabinoside in childhood. II. Cytosine arabinoside in the prevention and therapy of leukemic meningosis].
    Masi M; Paolucci P; Vivarelli F; Vecchi V
    Minerva Pediatr; 1975 Sep; 27(30):1624-31. PubMed ID: 1058332
    [No Abstract]   [Full Text] [Related]  

  • 20. High-dose cytosine arabinoside: advances in clinical pharmacology and therapeutic results.
    Woodruff RK; Wiley JS
    Aust N Z J Med; 1983 Dec; 13(6):561-3. PubMed ID: 6586146
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.